Jiawen Chen

4.2k citations
89 papers · 3.6k indexed · 2 hit papers · h-index 26

Jiawen Chen

82 papers receiving 3.6k citations

Hit Papers

Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Canc...5872017202620202023100200300400500

Peers

Jiawen Chen
Comparison fields: 5 of 144
  • Biomaterials 892
  • Biomedical Engineering 2.5k
  • Immunology 551
  • Materials Chemistry 1.0k
  • Cancer Research 262
Replace Kun Shi with:
Kun Shi China
Mei‐Zhen Zou China
Ke Li China
Haitao Ran China
Nitin Joshi United States
Jun Cao China
Claudia Corbo Italy
Jinrong Peng China
Jinfeng Liao China
Jiawen Chen relative to Kun Shi China Kun Shi's profile →
Citations per field
00.5×1.5×1.8×
Kun Shi · 1×
Citations per year

Countries citing papers authored by Jiawen Chen

Since Specialization
Citations

This map shows the geographic impact of Jiawen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiawen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiawen Chen more than expected).

Fields of papers citing papers by Jiawen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiawen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiawen Chen. The network helps show where Jiawen Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jiawen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jiawen Chen Line = papers co-authored together Jiawen Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20254
3 20243
4 20249
5 20240
6 20249
7 20235
8 202316
9 20233
10 20236
11 202310
12 202211
13 202211
14 20227
15 20222
16
A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation
20191
17 201938
18 201939
19 20170
20 20159

About Jiawen Chen

Jiawen Chen is a scholar working on Biomaterials, Issues, ethics and legal aspects and Biomedical Engineering, having authored 89 papers that have together received 3.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (22 papers), Electrospun Nanofibers in Biomedical Applications (8 papers), Tissue Engineering and Regenerative Medicine (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Hemostasis and retained surgical items (5 papers), Photodynamic Therapy Research Studies (5 papers), interferon and immune responses (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Biomaterials (892 citations), Biomedical Engineering (2.5k citations) and Immunology (551 citations). Jiawen Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhuang Liu, Qian Chen, Chao Liang, Zhijuan Yang, Liangzhu Feng, Xiao Han, Ziliang Dong, Ligeng Xu, Jun Xu and He Zhao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026